APA

Marshall A. D., Bailey C. G., Champ K., Vellozzi M., O'Young P., Metierre C., Feng Y., Thoeng A., Richards A. M., Schmitz U., Biro M., Jayasinghe R., Ding L., Anderson L., Mardis E. R. & Rasko J. E. J. (20170926). CTCF genetic alterations in endometrial carcinoma are pro-tumorigenic. : Oncogene.

Chicago

Marshall A D, Bailey C G, Champ K, Vellozzi M, O'Young P, Metierre C, Feng Y, Thoeng A, Richards A M, Schmitz U, Biro M, Jayasinghe R, Ding L, Anderson L, Mardis E R and Rasko J E J. 20170926. CTCF genetic alterations in endometrial carcinoma are pro-tumorigenic. : Oncogene.

Harvard

Marshall A. D., Bailey C. G., Champ K., Vellozzi M., O'Young P., Metierre C., Feng Y., Thoeng A., Richards A. M., Schmitz U., Biro M., Jayasinghe R., Ding L., Anderson L., Mardis E. R. and Rasko J. E. J. (20170926). CTCF genetic alterations in endometrial carcinoma are pro-tumorigenic. : Oncogene.

MLA

Marshall A D, Bailey C G, Champ K, Vellozzi M, O'Young P, Metierre C, Feng Y, Thoeng A, Richards A M, Schmitz U, Biro M, Jayasinghe R, Ding L, Anderson L, Mardis E R and Rasko J E J. CTCF genetic alterations in endometrial carcinoma are pro-tumorigenic. : Oncogene. 20170926.